March JAAD: Joint Position Statement on Routine Testing for Latent Tuberculosis Infection Prior to and During Treatment of Psoriasis Patients
June 22, 2026

Advances in psoriasis treatment have raised important questions about whether historical monitoring practices remain necessary for newer biologic agents. Join Sanna Ronkainen, MD and Andy Blauvelt, MD as they discuss the data informing updated recommendations on latent tuberculosis testing for patients treated with IL-17 and IL-23 inhibitors.
Summary
Availability:
On-Demand
Expires on Jun 22, 2029
Credit Offered:
0.5 CME Credit
Recommended

Legal notice
Copyright © 2026 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Android App Download IOS App Download Powered By